Pharma Reviews
Pages
Home
Pharma News
US FDA News
Pharma Jobs
Tuesday, July 18, 2017
US FDA News: FDA approves Vosevi for Hepatitis C
The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.
Read more:
FDA approves Vosevi for Hepatitis C
Newer Post
Older Post
Home
View mobile version